Posted on 08/01/2025 7:28:45 AM PDT by RandFan
A Senate panel voted Wednesday to approve a biomedical security bill sponsored by Sen. Rand Paul (R-KY) that would create an executive branch board to conduct oversight of life science research with pandemic-causing abilities, a measure inspired by the research conducted in Wuhan, China, prior to the COVID-19 pandemic.
The Risky Research Review Act advanced from the Senate Homeland Security and Government Affairs Committee in an 11-2 vote, with two Democrats voting against. The panel also approved the bill last Congress in an 8-1 vote, but it never received a vote on the Senate floor.
(Excerpt) Read more at washingtonexaminer.com ...
2) for those saying he doesn't accomplish anything well here's something. It could go to the floor this time.
Sen. Paul! Mr. Bureaucracy creator!
Ah yes, look another government committee to write even more strongly worded letters and tie up inconvenient truths in government red tape for years.
Ya nothing says action like more bureaucracy.
How about codifying - with PENALTIES, i.e., prison time and massive fines - against so-called Gain-of-Function activities in ALL civilian areas, private & government?
Maybe we should just wait until the Earth corrects its rotation and course changes and see if there is any humanity left after the collapse of the magnetic field, leaving Earth unprotected to be turned into a lifeless rock from the solar winds.
A rare misstep by Rand.
He is forgetting the axiom...”Before looking for ways the government can fix a problem, find out what the government did to cause the problem.”
What Fauci did with EcoHealth was already illegal.
Instead of creating a new government body, charge Fauci and everyone else involved with conspiracy and 1 million counts of murder and fry them.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.